Qualifying conditions include type 2 diabetes, prediabetes, high blood pressure, high cholesterol, sleep apnea, PCOS, fatty liver disease, cardiovascular disease, insulin resistance, metabolic syndrome, and weight-related joint pain
Why High-Dose B-12
Patients with longstanding type 2 diabetes often have substantial beta-cell loss, which can vary among individuals, potentially limiting their capacity to increase insulin secretion even with dual GIP/GLP-1 receptor stimulation
When examining the effects of BPC 157 on tail spasticity the results reported that development of spasticity began earlier in the test subjects treated with the peptide in comparison to the corresponding controls
Transparent Pricing: Clear, predictable costs without confusion